(Q40398904)

English

Tacrine

scientific article published on March 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

Tacrine (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

K L Davis

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

P Powchik

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 March 1995

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

345

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

8950

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

625-630

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral physostigmine treatment of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrine: A pharmacological review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple effects of tetrahydroaminoacridine on the cholinergic system: biochemical and behavioural aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of HP 029 (Velnacrine Maleate) in Alzheimer's Diseasea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrine in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a mental test score for assessment of mental impairment in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrine for Alzheimer's disease. Which patient, what dose?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990526-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(95)90526-X

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40398904&oldid=1896920752"